Regencell Bioscience Holdings (RGC) Common Equity (2020 - 2025)
Regencell Bioscience Holdings' (RGC) quarterly Common Equity came in at $1.2 million in Q4 2025, down 74.91% on a QoQ basis from $4.9 million in Q2 2025.
Regencell Bioscience Holdings (RGC) Common Equity (2020 - 2025) Analysis & Trends
Regencell Bioscience Holdings (RGC) has 6 years of Common Equity data on file, last reported at $1.2 million in Q4 2025.
- Quarterly Common Equity changed N/A year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (changed N/A YoY) and the FY2025 annual result came in at $4.9 million, down 40.86% from the prior year.
- Common Equity declined to $1.2 million in Q4 2025, from $4.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $17.1 million in Q2 2022 to a low of -$4.0 million in Q2 2021.
- A 5-year average of $6.6 million and a median of $6.5 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2021 — Common Equity tumbled 50.8% — and 2022, when it surged 527.27%.
- Tracing RGC's Common Equity over 5 years: stood at -$4.0 million in 2021, then surged by 527.27% to $17.1 million in 2022, then retreated by 29.81% to $12.0 million in 2023, then sank by 31.45% to $8.2 million in 2024, then tumbled by 85.16% to $1.2 million in 2025.
- The last three Common Equity figures came in at $1.2 million (Q4 2025), $4.9 million (Q2 2025), and $8.2 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Regencell Bioscience Holdings | 2.67 Bn | 2.67 Bn | - | 1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.22 Mn |
| Jun 30, 2025 | 4.86 Mn |
| Jun 30, 2024 | 8.22 Mn |
| Jun 30, 2023 | 11.99 Mn |
| Jun 30, 2022 | 17.08 Mn |
| Jun 30, 2021 | -4.00 Mn |
| Jun 30, 2020 | -2.65 Mn |